CorMedix (CRMD) Insider Trading & Ownership $14.80 +0.21 (+1.44%) As of 01:27 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CorMedix (NASDAQ:CRMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$14.99KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.57M Get CRMD Insider Trade Alerts Want to know when executives and insiders are buying or selling CorMedix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRMD Insider Buying and Selling by Quarter CorMedix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/14/2024Elizabeth HurlburtEVPSell140,027$11.18$1,565,501.86 10/31/2024Erin MistryEVPBuy1,500$9.99$14,985.00 (Data available from 1/1/2013 forward) CRMD Insider Trading Activity - Frequently Asked Questions Who is on CorMedix's Insider Roster? The list of insiders at CorMedix includes Elizabeth Hurlburt, Erin Mistry, and Joseph Todisco. Learn more on insiders at CRMD. What percentage of CorMedix stock is owned by insiders? 5.30% of CorMedix stock is owned by insiders. Learn more on CRMD's insider holdings. Which CorMedix insiders have been buying company stock? The following insiders have purchased CRMD shares in the last 24 months: Erin Mistry ($14,985.00), and Joseph Todisco ($87,818.14). How much insider buying is happening at CorMedix? Insiders have purchased a total of 25,061 CRMD shares in the last 24 months for a total of $102,803.14 bought. Which CorMedix insiders have been selling company stock? The following insider sold CRMD shares in the last 24 months: Elizabeth Hurlburt ($1,565,501.86). How much insider selling is happening at CorMedix? Insiders have sold a total of 140,027 CorMedix shares in the last 24 months for a total of $1,565,501.86 sold. CorMedix Key ExecutivesMr. Joseph Todisco MBA (Age 47)CEO & Director Compensation: $1.07MDr. Matthew T. David M.D. (Age 45)Executive VP & CFO Compensation: $597.27kMs. Erin Mistry (Age 41)Executive VP & Chief Commercial Officer Compensation: $561.57kMs. Elizabeth Masson-Hurlburt B.A. (Age 44)Executive VP and Chief Clinical Strategy & Operations Officer Compensation: $538.91kMs. Kaufman Beth Zelnick Esq.Executive VP, Chief Legal Officer & Corporate SecretaryDonna UcciSenior VP & Head of Global QualityDr. Tushar MukherjeeSenior VP & Head of Technical Operations More Insider Trading Tools from MarketBeat Related Companies Zai Lab Insider Transactions Ultragenyx Pharmaceutical Insider Transactions Arcellx Insider Transactions Protagonist Therapeutics Insider Transactions Catalyst Pharmaceuticals Insider Transactions Crinetics Pharmaceuticals Insider Transactions Viking Therapeutics Insider Transactions Scholar Rock Insider Transactions Kymera Therapeutics Insider Transactions MoonLake Immunotherapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:CRMD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
